These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16541967)

  • 1. Intranasal steroids: managing allergic rhinitis and tailoring treatment to patient preference.
    Meltzer EO
    Allergy Asthma Proc; 2005; 26(6):445-51. PubMed ID: 16541967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety considerations of intranasal corticosteroids for the treatment of allergic rhinitis.
    Blaiss MS
    Allergy Asthma Proc; 2007; 28(2):145-52. PubMed ID: 17479597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of intranasal corticosteroids in the management of pediatric allergic rhinitis.
    Kaari J
    Clin Pediatr (Phila); 2006 Oct; 45(8):697-704. PubMed ID: 16968954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment options for the management of perennial allergic rhinitis, with a focus on intranasal corticosteroids.
    Brunton SA; Fromer LM
    South Med J; 2007 Jul; 100(7):701-8. PubMed ID: 17639750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and tolerability of treatments for allergic rhinitis in children.
    Baena-Cagnani CE
    Drug Saf; 2004; 27(12):883-98. PubMed ID: 15366976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing rhinitis: Strategies for improved patient outcomes.
    Carr WW; Nelson MR; Hadley JA
    Allergy Asthma Proc; 2008; 29(4):349-57. PubMed ID: 18702880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concerns about intranasal corticosteroids for over-the-counter use: position statement of the Joint Task Force for the American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma and Immunology.
    Bielory L; Blaiss M; Fineman SM; Ledford DK; Lieberman P; Simons FE; Skoner DP; Storms WW; ;
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):514-25. PubMed ID: 16680921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal corticosteroids: the role of patient preference and satisfaction.
    Sher ER; Ross JA
    Allergy Asthma Proc; 2014; 35(1):24-33. PubMed ID: 24433594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal corticosteroids in the treatment of allergic rhinitis.
    Ratner PH; Stoloff S; Meltzer EO; Hadley JA
    Allergy Asthma Proc; 2007; 28 Suppl 1():S25-32. PubMed ID: 18307841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent pharmacological developments in the treatment of perennial and persistent allergic rhinitis.
    Klimek L; Mullol J; Hellings P; Gevaert P; Mösges R; Fokkens W
    Expert Opin Pharmacother; 2016; 17(5):657-69. PubMed ID: 26800187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caring for patients with allergic rhinitis.
    Hayden ML; Womack CR
    J Am Acad Nurse Pract; 2007 Jun; 19(6):290-8. PubMed ID: 17535338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes and adverse effect monitoring in allergic rhinitis.
    Juniper EF; Ståhl E; Doty RL; Simons FE; Allen DB; Howarth PH
    J Allergy Clin Immunol; 2005 Mar; 115(3 Suppl 1):S390-413. PubMed ID: 15746880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of allergic rhinitis].
    Tas E; Bircher AJ
    Ther Umsch; 2001 May; 58(5):309-14. PubMed ID: 11407233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of intranasal corticosteroids.
    Bensch GW
    Ann Allergy Asthma Immunol; 2016 Dec; 117(6):601-605. PubMed ID: 27979016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of study design on the evaluation of inhaled and intranasal corticosteroids' effect on hypothalamic-pituitary-adrenal axis function, part I: general overview of HPA axis study design.
    Fan Y; Ma L; Pippins J; Limb S; Xu Y; Sahajwalla CG
    J Pharm Sci; 2013 Oct; 102(10):3513-27. PubMed ID: 23918409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy in the treatment of allergic rhinitis.
    Weinstein SF
    Allergy Asthma Proc; 2002; 23(1):1-3. PubMed ID: 11894728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergic rhinitis: managing the pediatric spectrum.
    Meltzer EO
    Allergy Asthma Proc; 2006; 27(1):2-8. PubMed ID: 16598985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciclesonide, a hypotonic intranasal corticosteroid.
    Neffen H; Wingertzahn MA
    Allergy Asthma Proc; 2010; 31 Suppl 1():S29-37. PubMed ID: 20557684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluticasone furoate: a new intranasal corticosteroid.
    Kumar R; Kumar D; Parakh A
    J Postgrad Med; 2012; 58(1):79-83. PubMed ID: 22387656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No hypothalamic-pituitary-adrenal function effect with beclomethasone dipropionate nasal aerosol, based on 24-hour serum cortisol in pediatric allergic rhinitis.
    Hampel FC; Nayak NA; Segall N; Small CJ; Li J; Tantry SK
    Ann Allergy Asthma Immunol; 2015 Aug; 115(2):137-42. PubMed ID: 26250771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.